[HTML][HTML] Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination
When vaccines are in limited supply, expanding the number of people who receive some
vaccine, such as by halving doses or increasing the interval between doses, can reduce …
vaccine, such as by halving doses or increasing the interval between doses, can reduce …
Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research
JM Ferdinands, MG Thompson, L Blanton, S Spencer… - Vaccine, 2021 - Elsevier
The effect of influenza vaccination on influenza severity remains uncertain. We reviewed the
literature for evidence to inform the question of whether influenza illness is less severe …
literature for evidence to inform the question of whether influenza illness is less severe …
Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines
MG Thompson, JL Burgess, AL Naleway… - … England Journal of …, 2021 - Mass Medical Soc
Background Information is limited regarding the effectiveness of the two-dose messenger
RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in …
RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in …
Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19) …
L Kim, S Garg, A O'Halloran, M Whitaker… - Clinical infectious …, 2021 - academic.oup.com
Abstract Background Currently, the United States has the largest number of reported
coronavirus disease 2019 (COVID-19) cases and deaths globally. Using a geographically …
coronavirus disease 2019 (COVID-19) cases and deaths globally. Using a geographically …
Safety and efficacy of single-dose Ad26. COV2. S vaccine against Covid-19
J Sadoff, G Gray, A Vandebosch… - … England Journal of …, 2021 - Mass Medical Soc
Abstract Background The Ad26. COV2. S vaccine is a recombinant, replication-incompetent
human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome …
human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome …
[HTML][HTML] Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2019–20 …
LA Grohskopf - MMWR. Recommendations and Reports, 2019 - cdc.gov
This report updates the 2018–19 recommendations of the Advisory Committee on
Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the …
Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the …
Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials
J Hawkins, C Baker, L Cherry, E Dunne - Complementary therapies in …, 2019 - Elsevier
Upper respiratory symptoms are often treated with over the counter drugs, antibiotics, and
antiviral medications. Due to concerns about safety and efficacy, there is a demand for an …
antiviral medications. Due to concerns about safety and efficacy, there is a demand for an …
Acute cardiovascular events associated with influenza in hospitalized adults: a cross-sectional study
EJ Chow, MA Rolfes, A O'Halloran… - Annals of internal …, 2020 - acpjournals.org
Background: Influenza may contribute to the burden of acute cardiovascular events during
annual influenza epidemics. Objective: To examine acute cardiovascular events and …
annual influenza epidemics. Objective: To examine acute cardiovascular events and …
[HTML][HTML] Influenza virus-related critical illness: prevention, diagnosis, treatment
EJ Chow, JD Doyle, TM Uyeki - Critical Care, 2019 - Springer
Annual seasonal influenza epidemics of variable severity result in significant morbidity and
mortality in the United States (US) and worldwide. In temperate climate countries, including …
mortality in the United States (US) and worldwide. In temperate climate countries, including …
Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012 …
Background Little is known about inactivated influenza vaccine effectiveness (IVE) in
preventing very severe disease, including influenza-associated intensive care unit (ICU) …
preventing very severe disease, including influenza-associated intensive care unit (ICU) …